Catalyst Pharma
CPRX31.4900.00% ( 0.000 )
Catalyst Pharma (CPRX)
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 31.490
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 32.560
- Volume Ratio
- 0.00
- Turnover Ratio
- --
Catalyst Pharma Analyst Rating
View MoreForecast & Rating
Jun 12, 2026Price forecast
$31.670.56%
Forecast & RatingHold
4analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · Jul 16 at 05:03 AM
Catalyst Pharmaceuticals directors resign; Merger Sub directors join board
- TradingView · Jul 16 at 05:03 AM
Catalyst Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing
- Market Beat · Jul 15 at 12:02 PM
Pharmaceutical Stocks To Watch Today - July 15th
- Simplywall · Jul 13 at 04:08 AM
Catalyst Pharmaceuticals (CPRX) Could Be 60% Undervalued As Merger Approval Reshapes The Board
- MSN · Jul 10 at 02:59 PM
Why Solaris Energy Infrastructure (SEI) stock is up today
- Market Beat · Jul 10 at 05:03 AM
Catalyst Pharmaceuticals Stockholders Clear Angelini Pharma Merger
